Oh YK[au] - Search Results

Year	Number of Results
1964	1
1966	1
1967	1
1968	1
1969	1
1974	1
1975	2
1976	1
1978	2
1979	1
1980	1
1981	2
1983	1
1984	1
1985	2
1986	5
1987	2
1988	1
1995	1
1996	5
1997	2
1998	1
1999	6
2000	7
2001	9
2002	13
2003	16
2004	10
2005	17
2006	14
2007	21
2008	21
2009	26
2010	40
2011	41
2012	34
2013	33
2014	48
2015	41
2016	37
2017	47
2018	34
2019	46
2020	53
2021	45
2022	35
2023	28
2024	9

1

Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.

Baek SH, Jo YH, Ahn S, Medina-Liabres K, Oh YK, Lee JB, Kim S. Baek SH, et al. Among authors: oh yk. JAMA Intern Med. 2021 Jan 1;181(1):81-92. doi: 10.1001/jamainternmed.2020.5519. JAMA Intern Med. 2021. PMID: 33104189 Free PMC article. Clinical Trial.

2

Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer Therapy.

Kang M, Lee SH, Kwon M, Byun J, Kim D, Kim C, Koo S, Kwon SP, Moon S, Jung M, Hong J, Go S, Song SY, Choi JH, Hyeon T, Oh YK, Park HH, Kim BS. Kang M, et al. Among authors: oh yk. Adv Mater. 2021 Oct;33(43):e2103258. doi: 10.1002/adma.202103258. Epub 2021 Sep 12. Adv Mater. 2021. PMID: 34510559

3

Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing.

Kim H, Park HC, Ryu H, Kim H, Lee HS, Heo J, Lee C, Kim NKD, Park WY, Hwang YH, Lee KB, Oh KH, Oh YK, Ahn C. Kim H, et al. Among authors: oh yk. Sci Rep. 2019 Nov 18;9(1):16952. doi: 10.1038/s41598-019-52474-1. Sci Rep. 2019. PMID: 31740684 Free PMC article.

4

CRS Local chapters special issue 2023.

Oh YK, Schroeder A, Sarmento B. Oh YK, et al. Drug Deliv Transl Res. 2023 May;13(5):1169. doi: 10.1007/s13346-023-01324-9. Epub 2023 Mar 14. Drug Deliv Transl Res. 2023. PMID: 36917410 No abstract available.

5

Nanomaterials for antigen-specific immune tolerance therapy.

Park J, Wu Y, Li Q, Choi J, Ju H, Cai Y, Lee J, Oh YK. Park J, et al. Among authors: oh yk. Drug Deliv Transl Res. 2023 Jul;13(7):1859-1881. doi: 10.1007/s13346-022-01233-3. Epub 2022 Sep 12. Drug Deliv Transl Res. 2023. PMID: 36094655 Review.

6

RNA Nanomedicine: Delivery Strategies and Applications.

Byun J, Wu Y, Park J, Kim JS, Li Q, Choi J, Shin N, Lan M, Cai Y, Lee J, Oh YK. Byun J, et al. Among authors: oh yk. AAPS J. 2023 Oct 2;25(6):95. doi: 10.1208/s12248-023-00860-z. AAPS J. 2023. PMID: 37784005 Review.

7

Management of Osteoporosis Medication after Osteoporotic Fracture.

Oh YK, Moon NH, Shin WC. Oh YK, et al. Hip Pelvis. 2022 Dec;34(4):191-202. doi: 10.5371/hp.2022.34.4.191. Epub 2022 Dec 3. Hip Pelvis. 2022. PMID: 36601612 Free PMC article. Review.

8

Nanoformulation-based sequential combination cancer therapy.

Shim G, Kim MG, Kim D, Park JY, Oh YK. Shim G, et al. Among authors: oh yk. Adv Drug Deliv Rev. 2017 Jun 1;115:57-81. doi: 10.1016/j.addr.2017.04.003. Epub 2017 Apr 12. Adv Drug Deliv Rev. 2017. PMID: 28412324 Review.

9

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing.

Kim D, Le QV, Wu Y, Park J, Oh YK. Kim D, et al. Among authors: oh yk. Pharmaceutics. 2020 Dec 18;12(12):1233. doi: 10.3390/pharmaceutics12121233. Pharmaceutics. 2020. PMID: 33353099 Free PMC article. Review.

10

Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.

Le QV, Suh J, Oh YK. Le QV, et al. Among authors: oh yk. AAPS J. 2019 May 17;21(4):64. doi: 10.1208/s12248-019-0333-y. AAPS J. 2019. PMID: 31102154 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

668 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Results by year